Higgins; Linda S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Higgins; Linda S..The latest application filed is for "method of treating myelodysplastic syndromes".

Company Profile

0.6.17

Higgins; Linda S. - Marblehead MA
Higgins; Linda S. - Palo Alto CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
System and method to customize the facilitation of development of user thinking about and documenting of an arbitrary problem Grant 7,349,888 - Heidenreich , et al. March 25, 2	2008-03-25
System and method to facilitate user thinking about an arbitrary problem with output and interface to external components and resources Grant 7,260,561 - Heidenreich , et al. August 21, 2	2007-08-21
System and method of facilitating and evaluating user thinking about an arbitrary problem using visual feedback Grant 7,225,175 - Higgins , et al. May 29, 2	2007-05-29
System and method of facilitating and evaluating user thinking about an arbitrary problem using an archetype process Grant 7,203,667 - Higgins , et al. April 10, 2	2007-04-10
System and method of facilitating and evaluating user thinking about an arbitrary problem using an archetype problem structure Grant 7,197,488 - Higgins , et al. March 27, 2	2007-03-27
System and method of facilitating and evaluating user thinking about an arbitrary problem Grant 7,143,074 - Higgins , et al. November 28, 2	2006-11-28
Method of treating myelodysplastic syndromes App 20060258582 - Navas; Mario A. ; et al.	2006-11-16
Prevention and treatment of amyloid-associated disorders App 20060210964 - Hyslop; Paul Andrew ; et al.	2006-09-21
Treatment of multiple myeloma by inhibition of p38 MAP kinase App 20060079461 - Brewer; Richard ; et al.	2006-04-13
Treatment of osteolytic lesions associated with multiple myeloma by inhibition of p38 map kinase App 20060058296 - Higgins; Linda S. ; et al.	2006-03-16
Treatment of multiple myeloma by p38 MAP kinase and proteasome inhibition App 20060052390 - Schreiner; George F. ; et al.	2006-03-09
Treatment of cardiovascular disease with inhibitors of p38 kinase App 20060019971 - Higgins; Linda S. ; et al.	2006-01-26
Treatment of malignant gliomas with TGF-beta inhibitors App 20050245508 - Weller, Michael ; et al.	2005-11-03
System and method of facilitating and evaluating user thinking about an arbitrary problem App 20050154691 - Higgins, Linda S. ; et al.	2005-07-14
Differential inhibition of p38 map kinase isoforms App 20050043212 - Kirschenbaum, Ford ; et al.	2005-02-24
Use of TGF-beta inhibitors to counteract pathologic changes in the level or function of steroid/thyroid receptors App 20040138188 - Higgins, Linda S. ; et al.	2004-07-15
Method for counteracting a pathologic change in the beta-adrenergic pathway App 20040127575 - Ying, Feng ; et al.	2004-07-01
System and method of facilitating and evaluating user thinking about an arbitrary problem using an archetype process App 20040106090 - Higgins, Linda S. ; et al.	2004-06-03
System and method of facilitating and evaluating user thinking about an arbitrary problem using an archetype problem structure App 20040106089 - Higgins, Linda S. ; et al.	2004-06-03
System and method of facilitating and evaluating user thinking about an arbitrary problem using visual feedback App 20040098357 - Higgins, Linda S. ; et al.	2004-05-20
Prevention and treatment of amyloid-associated disorders App 20040067538 - Hyslop, Paul Andrew ; et al.	2004-04-08
Treatment of fibroproliferative disorders using TGF-beta inhibitors App 20040038856 - Chakravarty, Sarvajit ; et al.	2004-02-26
Method to treat cystic fibrosis App 20040009990 - Higgins, Linda S. ; et al.	2004-01-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.